Marvin Slosman insider trades: InspireMD (NSPR) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Marvin reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 12, 2026 | NSPR | ↑ Buy | 21,000 | $1.20 | $25K | Direct | May 13, 2026 (1d) |
| Jul 30, 2025 | NSPR | ↑ Buy | 10,330 | $2.42 | $25K | Direct | Aug 1, 2025 (2d) |
| Feb 8, 2021 | NSPR | ↑ Buy | 40,320 | $0.62 | $25K | Direct | Feb 10, 2021 (2d) |
| Jun 5, 2020 | NSPR | ↑ Buy | 55,550 | $0.45 | $25K | Direct | Jun 9, 2020 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other NSPR insiders
Open-market trades in the last 12 months
About Marvin Slosman's insider trades
Marvin Slosman is CEO and President at InspireMD (NSPR). Since Jun 5, 2020, Marvin has reported 4 open-market purchases worth $100K and no sales on SEC Form 4. In the last 12 months: 1 buy ($25K).
Their filings also include grants and awards (11 filings), other transactions (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every NSPR insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.